Cannell & Co’s Exact Sciences EXAS Stock Holding History

Cannell & Co’s Portfolio EXAS Stock Details EXAS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-467,933	Closed	-$40.7M	–	250
2020 Q2	$40.7M	Buy	+467,933	New	+$37.4M	1.6%	18

Other funds holding EXAS

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return

Cannell & Co's EXAS Position: Q3 2020 in Review

Cannell & Co sold out of Exact Sciences (EXAS) in Q3 2020, closing a stake of 467,933 shares — an estimated $40.7M sold.

Cannell & Co first reported a position in EXAS in Q2 2020 and held it in 1 quarter. The position peaked at $40.7M in Q2 2020. 517 funds tracked by Wall St. Rank hold EXAS as of Q3 2020.

Cannell & Co reported no remaining Exact Sciences position as of Q3 2020 after selling out during the quarter.
Cannell & Co sold 467,933 Exact Sciences shares in Q3 2020, an estimated $40.7M.
Cannell & Co first reported a position in Exact Sciences in Q2 2020 and held it in 1 quarter.
Cannell & Co's Exact Sciences position peaked at $40.7M in Q2 2020.
517 funds tracked by Wall St. Rank held Exact Sciences as of Q3 2020.

Based on Cannell & Co's 13F filing for Q3 2020, filed 12 Nov 2020.